KLCA대한간암학회는간암 진료와 연구, 정책 마련의 핵심이 되는 학회입니다.

GENERAL SYMPOSIUM총회심포지엄

제 22차 대한간암학회 총회 심포지엄 - The Liver Week 2019

  • KLCA Syposium 1. Developing Strategy to Improve Diagnosis of HCC
  • Surveillances for HCC in Patients with Non-Alcoholic Fatty Liver Disease - Vincent Wong (The Chinese Univ. of Hong Kong)
  • Are Emerging Biomarkers and Imaging Tools Better than Routine Abdominal Sonography for HCC Surveillance? - Do Young Kim (Yonsei Univ.)
  • Is LI-RADS Better for Diagnosis of HCC - Jeong Min Lee (Seoul National Univ.)
  • LCSGJ-KLCA Joint Symposium 1. One Step Forward for Understanding Basic Knowledge
  • Circulating Tumor Cells and Cell-Free Nucleic Acids - Takahiro Ochiya (Tokyo Medical Univ., Japan)
  • CAR-Associated Adoptive Immunotherapy - Yutaka Kawakami (Keio Univ., Japan)
  • Oncolytic Virus-Based Therapy for HCC - Jeong Heo (Pusan National Univ.)
  • LCSGJ-KLCA Joint Symposium 2. Similarities and Differences in Treatment of HCC
  • Recent Trends of Treatment for Intermediate Stage HCC: Japanese Experience - Masatoshi Kudo (Kindai Univ., Japan)
  • Recent Trends of Treatment for Intermediate Stage HCC: Korean Experience - Ji Hoon Kim (Korea Univ.)
  • Recent Trends of Treatment for Advanced Stage HCC: Japanese Experience - Kazuomi Ueshima (Kindai Univ., Japan)
  • Recent Trends of Treatment for Advanced Stage HCC: Korean Experience - Won Young Tak (Kyungpook National Univ.)
  • KLCA Symposium 2. New and Emerging Systemic Therapies in Advanced HCC
  • First Line Treatments for HCC - Arndt Vogel (Hannover Medical School, Germany)
  • Second Line Treatments for HCC - Stephen Chan (The Chinese Univ. of Hong Kong)
  • A Future of Systemic Agents: Emerging Therapies and Strategies - Baek-Yeol Ryoo (Univ. of Ulsan)
  • Combination of Interventional and Systemic Therapies: Current Status and Future Direction - Joong-Won Park (National Cancer Center)